Azacitidine
- Product NDC
- 68001-504
- 11-digit product format
- 680010504
- Labeler code
- 68001
- Product ID
- 68001-504_c32554cb-be86-d0d7-e053-2995a90a63a0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Azacitidine
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- BluePoint Laboratories
- Application
- ANDA207234
- Marketing category
- ANDA
- Marketing start
- 2021-06-11
- Marketing end
- 0000-00-00
- Substance
- AZACITIDINE
- Active strength
- 100 mg/50mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68001-504-54 | 68001050454 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-504-54) > 50 mL in 1 VIAL, SINGLE-DOSE | 2021-06-11 | 0000-00-00 | No | No | Current |